AngioDynamics
ANGO
150 hedge funds and large institutions have $366M invested in AngioDynamics in 2025 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 55 increasing their positions, 53 reducing their positions, and 22 closing their positions.
121% more call options, than puts
Call options by funds: $491K | Put options by funds: $222K
10% more capital invested
Capital invested by funds: $332M → $366M (+$34M)
3.55% more ownership
Funds ownership: 87.14% → 90.69% (+3.6%)
4% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 53
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less funds holding
Funds holding: 154 → 150 (-4)
14% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$23.8M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$9.99M |
| 3 |
BAM
Bastion Asset Management
Montreal,
Canada
|
+$2.98M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$2.46M |
| 5 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$1.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$5.54M |
| 2 |
Morgan Stanley
New York
|
-$4.1M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
-$2.84M |
| 4 |
JP Morgan Chase
New York
|
-$2.48M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$2.18M |
ANGO Hedge Fund Activity: Q2 2025 in Review
150 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q2 2025, worth a combined $366M — up 10% from $332M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of ANGO and 19 opened new positions — a net loss of 3 holders — while 53 trimmed existing stakes and 55 added.
The largest buyer was Divisadero Street Capital Management, adding an estimated $23.8M. The largest seller was Armistice Capital, cutting an estimated $5.54M.
- 150 institutional investors held AngioDynamics (ANGO) as of Q2 2025, down from 154 in Q1 2025.
- Funds reported $366M of AngioDynamics stock for Q2 2025, up 10% quarter-over-quarter.
- 19 funds opened new AngioDynamics positions in Q2 2025 and 22 closed out, a net change of -3 holders.
- The largest AngioDynamics buyer in Q2 2025 was Divisadero Street Capital Management, an estimated $23.8M added.
- The largest AngioDynamics seller in Q2 2025 was Armistice Capital, an estimated $5.54M sold.
Based on aggregated 13F filings for Q2 2025.